Literature DB >> 508892

Anti-tumour effect of an aromatic retinoic acid analog in a mouse syngeneic transplantable sarcoma.

J M Deneufbourg.   

Abstract

Anti-tumour activity of an aromatic retinoic acid analog has been tested on Sarcoma J in syngeneic system. Tumour complete regression rate and median survival time of progressors mice are significantly improved. These results are at variance with previous observations suggesting the lack of activity of this compound on transplanted murine tumours. Arguments in favour of an immunological stimulation responsible for the observed anti-tumour effect are presented and discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508892

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


  2 in total

1.  Activity of a novel carotenoid analog, 4,4'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaen -1,18- diyl) bis(1-ethylpyridinium) dibromide (Y-18598) on mouse leukemia P388.

Authors:  T Okumoto; N Morita; I Nakamura; M Konishi; M Yamaguchi
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

2.  Inhibition of growth and spontaneous metastasis of syngeneic transplantable tumors by an aromatic retinoic acid analogue. 1. Relationship between tumour immunogenicity and responsiveness.

Authors:  S A Eccles; S C Barnett; P Alexander
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.